 Health Newstrack |
Avastin No Help in Advanced NSCLC
MedPage Today This study found that adding bevacizumab (Avastin) to chemotherapy doesn't prolong life for seniors more than 65 with advanced non-small cell lung cancer (NSCLC). Note that none of the propensity-adjusted models controlling for demographic and clinical … Bevacizumab Not Effective in Advanced Lung Cancer in the Elderly Adding Drug to Standard Chemotherapy Provides No Survival Benefit for Older … Study examines drug regimen for the treatment of non-small cell lung cancer … |
View full post on lung cancer – Google News
